CAQ-EM study materials
CAQ-EM study resources

Tongue and Floor-of-Mouth Swelling on an ACE Inhibitor

CAQ-EM · Put your knowledge to work in context.

All case studies

Tongue and Floor-of-Mouth Swelling on an ACE Inhibitor

A 64-year-old woman presents with 90 minutes of progressive tongue and lower-lip swelling. She has taken lisinopril 20 mg daily for 14 months and reports two earlier self-limited episodes of lip swelling that resolved within 24 hours without treatment. She has no urticaria, no pruritus, and no new foods, medications, or insect exposures. She speaks with a muffled voice and is drooling. There is no stridor at rest, but inspiratory stridor is audible when she lies flat. Vital signs: temperature 37.1 degrees C, pulse 104, blood pressure 156/92 mmHg, respiratory rate 22, SpO2 97% on room air. The tongue is markedly edematous and the floor of the mouth is not indurated; there is no dental infection. Triage has already given IM epinephrine 0.3 mg, diphenhydramine 50 mg, and methylprednisolone 125 mg IV, with no change over 20 minutes.

1. What is the mechanism of this reaction, and why has the standard anaphylaxis bundle failed? Which specific therapies would you give next?

Read the worked answer

Mechanism: bradykinin-mediated angioedema. ACE is kininase II; blocking it reduces degradation of bradykinin and substance P, which increases vascular permeability and produces non-pitting, non-urticarial swelling of the lips, tongue, and larynx. It can begin months to years after the first dose, and it is not IgE-mediated, so there is no mast cell degranulation to treat.

Why the bundle failed. Epinephrine, antihistamines, and steroids target histamine-driven pathways. They are close to useless here, though epinephrine is reasonable while the diagnosis is still uncertain or if there is any chance of a mixed picture or anaphylaxis. Her lack of urticaria, pruritus, and new exposures, plus the long ACE-inhibitor exposure and prior self-limited episodes, strongly favors bradykinin.

Next therapies

  • Icatibant 30 mg subcutaneously: a bradykinin B2 receptor antagonist, used off-label for ACE-inhibitor angioedema but supported by case series; best given early.
  • C1 esterase inhibitor concentrate 20 units/kg IV, or fresh frozen plasma 2 units if the specific agents are unavailable (FFP supplies ACE, both a rationale for benefit and a theoretic risk of worsening).
  • Tranexamic acid 1 g IV is an option where the above are unavailable.
  • Stop lisinopril permanently and document it as an allergy.
  • Continue airway monitoring in a resuscitation bay; these patients can obstruct within minutes.

Caveat. None of these is a substitute for airway planning. Do not wait for the medication to work before securing the airway if the trajectory is worsening.

2. How do you plan and time the airway management? Explain what you would avoid and what you would prepare.

Read the worked answer

Recognize impending obstruction. Drooling, a muffled voice, and position-dependent stridor are not reassurance signs; they mean the airway is narrowing and will narrow further. The safest intubation is the one done early, in a controlled setting, with the best operator and equipment, before the anatomy becomes distorted.

Plan

  • Move to the resuscitation bay, sit the patient upright, give high-flow oxygen, and keep her calm; agitation and crying worsen edema.
  • Call anesthesia and ENT/head and neck surgery now, simultaneously. The surgeon should be at the bedside with a cricothyrotomy tray open, not on call.
  • Perform an awake, spontaneously breathing intubation using video laryngoscopy or a flexible scope with topical anesthesia and gentle sedation that preserves respiratory drive. Have multiple blade sizes, a bronchoscope, and a supraglottic rescue device ready.
  • Preoxygenate well, use suction continuously, and prepare for a cannot-intubate/cannot-oxygenate pathway.

Avoid

  • Blind nasotracheal intubation: trauma and bleeding in an edematous airway make a bad situation worse.
  • Deep paralysis before you know you can intubate, unless you are committed to an immediate surgical airway.
  • Supine positioning, which is when her stridor appears.
  • Waiting for the swelling to plateau. In bradykinin angioedema, deterioration can be abrupt.

If the airway is lost. Have a scalpel-bougie cricothyrotomy plan verbalized to the team, and make sure the person expected to do it is physically present. If intubation succeeds, keep the tube in place and plan for ICU-level observation, because the airway can remain edematous for 24-72 hours.

3. Assuming the airway is secured and the swelling begins to resolve, how do you dispose of her, and what counseling and follow-up decisions are required?

Read the worked answer

Disposition. ICU or a monitored step-down unit for at least 24-72 hours. Bradykinin angioedema can recur or rebound, particularly after icatibant, whose half-life is far shorter than the ongoing activation of the kinin pathway. Rebound laryngeal edema after apparent improvement is well described. Serial assessments of voice, swallowing, and stridor, plus an anesthesiologist and surgeon available for re-intubation, matter more than the absolute time window.

Medications. Stop lisinopril permanently. There is no evidence that steroids or antihistamines prevent recurrence, so do not send her home on them as a precaution. The earlier episodes of self-limited lip swelling were warning shots and should have prompted stopping the drug.

Counseling

  • Document loudly in the chart and give written information: ACE inhibitors must never be restarted. Recurrence can be fatal.
  • ARBs carry a lower but real cross-reactivity risk; most specialists avoid them in these patients. If blood pressure control is needed, choose a thiazide, calcium channel blocker, or beta-blocker, and let her primary care physician know the reason for the switch.
  • She should avoid the entire ACE-inhibitor class, including combination products that contain one under a different name.
  • Discuss an emergency plan: return immediately for any lip, tongue, or throat swelling, and consider a letter for travel or future care.

Other considerations. Screen for airway injury from intubation, arrange ENT and allergy follow-up, and ask about a family history of hereditary angioedema if the picture was atypical. Recurrence risk after an episode is high enough that the counseling must be explicit and verified as understood.